CD26 mRNA Expression Level In Systemic lupus Erythematosus Patients Attending Benha University Hospital
暂无分享,去创建一个
[1] Xiangli Zhao,et al. Delayed allogeneic skin graft rejection in CD26-deficient mice , 2018, Cellular & Molecular Immunology.
[2] D. Tarlinton,et al. Lyn, Lupus, and (B) Lymphocytes, a Lesson on the Critical Balance of Kinase Signaling in Immunity , 2018, Front. Immunol..
[3] A. Ahmadzadeh,et al. CD 26 mRNA expression in Systemic Lupus Erythematosus , 2018 .
[4] C. Klemann,et al. Cut to the chase: a review of CD26/dipeptidyl peptidase‐4's (DPP4) entanglement in the immune system , 2016, Clinical and experimental immunology.
[5] Grainne Murphy,et al. Effect of gender on clinical presentation in systemic lupus erythematosus. , 2013, Rheumatology.
[6] Gerald McGwin,et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. , 2012, Arthritis and rheumatism.
[7] K. Hara,et al. Serum level of soluble CD26/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes controlled inadequately by metformin and/or sulfonylurea. , 2012, Translational research : the journal of laboratory and clinical medicine.
[8] C. Lam,et al. Decreased Expression of T Lymphocyte Co-Stimulatory Molecule CD26 on Invariant Natural Killer T Cells in Systemic Lupus Erythematosus , 2009, Immunological investigations.
[9] A. Braun,et al. CD26 (dipeptidyl‐peptidase IV)‐dependent recruitment of T cells in a rat asthma model , 2005, Clinical and experimental immunology.
[10] T. Mimori,et al. Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus. , 2002, The Journal of rheumatology.
[11] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[12] D. Sackett,et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. , 1992, Arthritis and rheumatism.
[13] T. Nagatsu,et al. Activities of dipeptidyl peptidase II and dipeptidyl peptidase IV in mice with lupus erythematosus-like syndrome and in patients with lupus erythematosus and rheumatoid arthritis. , 1987, Clinical chemistry.